Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes

Diabetologia

Volumn 54, Issue 5, 2011, Pages 1136-1146

  Lee, S M ^a,b   Yang, H ^a   Tartar, D M ^c   Gao, B ^a   Luo, X ^a   Ye, S Q ^d   Zaghouani, H ^c   Fang, D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Chonbuk National University   (South Korea)

^c University of Missouri   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

C C chemokine receptor 6; CCR6; Disease prevention; Resveratrol; Type 1 diabetes

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 17; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; RESVERATROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATORY CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; MACROPHAGE; MICROARRAY ANALYSIS; MIGRATION INHIBITION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL20; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; HYPOGLYCEMIC AGENTS; INTERLEUKIN-17; MICE; MICE, INBRED NOD; RECEPTORS, CCR6; STILBENES;

EID: 79954632388     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2064-1     Document Type: Article

References (46)

1. A Schoppner H Kindl 1984 Purification and properties of a stilbene synthase from induced cell suspension cultures of peanut J Biol Chem 259 6806 6811 6427224 1:STN:280:DyaL2c3ht1Giuw%3D%3D
2. JC Milne PD Lambert S Schenk, et al. 2007 Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes Nature 450 712 716 18046409 10.1038/nature06261 1:CAS:528:DC%2BD2sXhtlKmtbrM (Pubitemid 350207685)
3. AA Bertelli DK Das 2009 Grapes, wines, resveratrol, and heart health J Cardiovasc Pharmacol 54 468 476 19770673 10.1097/FJC.0b013e3181bfaff3 1:CAS:528:DC%2BD1MXhsF2gsbnF
4. A Bishayee T Politis AS Darvesh 2010 Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma Cancer Treat Rev 36 43 53 19910122 10.1016/j.ctrv.2009.10.002 1:CAS:528:DC%2BC3cXhtlyjtbg%3D
5. KB Harikumar BB Aggarwal 2008 Resveratrol: a multitargeted agent for age-associated chronic diseases Cell Cycle 7 1020 1035 18414053 10.4161/cc.7.8.5740 1:CAS:528:DC%2BD1cXnvVSrsLY%3D
6. S Das DK Das 2007 Anti-inflammatory responses of resveratrol Inflamm Allergy Drug Targets 6 168 173 17897053 10.2174/187152807781696464 1:CAS:528:DC%2BD2sXht1SjsrvN (Pubitemid 47455785)
7. TJ Imler Jr TM Petro 2009 Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression Int Immunopharmacol 9 134 143 19022403 10.1016/j.intimp.2008.10.015 1:CAS:528:DC%2BD1MXkt1WktQ%3D%3D
8. NP Singh VL Hegde LJ Hofseth M Nagarkatti P Nagarkatti 2007 Resveratrol (trans-3, 5, 4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor Mol Pharmacol 72 1508 1521 17872969 10.1124/mol.107.038984 1:CAS:528:DC%2BD2sXhsVagsr7F (Pubitemid 350146088)
9. YH Hsieh SS Huang FC Wei LM Hung 2007 Resveratrol attenuates ischemia-reperfusion-induced leukocyte-endothelial cell adhesive interactions and prolongs allograft survival across the MHC barrier Circ J 71 423 428 17322646 10.1253/circj.71.423 1:CAS:528:DC%2BD2sXjsF2ktL4%3D (Pubitemid 46409549)
10. SL Wu L Yu XY Jiao KW Meng CE Pan 2006 The suppressive effect of resveratrol on protein kinase C theta in peripheral blood T lymphocytes in a rat liver transplantation model Transplant Proc 38 3052 3054 17112897 10.1016/j.transproceed.2006.08.150 1:CAS:528:DC%2BD28Xht1CisrbN (Pubitemid 44737948)
11. M Stefani MA Markus RC Lin M Pinese IW Dawes BJ Morris 2007 The effect of resveratrol on a cell model of human aging Ann N Y Acad Sci 1114 407 418 17804521 10.1196/annals.1396.001 1:CAS:528:DC%2BD2sXhsVGqu7fE (Pubitemid 350070370)
12. JN Feige M Lagouge C Canto, et al. 2008 Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation Cell Metab 8 347 358 19046567 10.1016/j.cmet.2008.08.017 1:CAS:528:DC%2BD1cXhtlOgur7O
13. PJ Elliott M Jirousek 2008 Sirtuins: novel targets for metabolic disease Curr Opin Investig Drugs 9 371 378 18393104 1:CAS:528:DC%2BD1cXmtFygsbs%3D (Pubitemid 351507663)
14. K Subbaramaiah WJ Chung P Michaluart, et al. 1998 Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells J Biol Chem 273 21875 21882 9705326 10.1074/jbc.273.34.21875 1:CAS:528:DyaK1cXlsFOqsb0%3D (Pubitemid 28405365)
15. MT Borra BC Smith JM Denu 2005 Mechanism of human SIRT1 activation by resveratrol J Biol Chem 280 17187 17195 15749705 10.1074/jbc.M501250200 1:CAS:528:DC%2BD2MXjsFOgtb8%3D (Pubitemid 41389185)
16. M Kaeberlein T McDonagh B Heltweg, et al. 2005 Substrate-specific activation of sirtuins by resveratrol J Biol Chem 280 17038 17045 15684413 10.1074/jbc.M500655200 1:CAS:528:DC%2BD2MXjsFOgt7w%3D (Pubitemid 41389166)
17. Y Kobayashi Y Furukawa-Hibi C Chen, et al. 2005 SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress Int J Mol Med 16 237 243 16012755 1:CAS:528:DC%2BD2MXnslykt7w%3D
18. J Zhang SM Lee S Shannon, et al. 2009 The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice J Clin Invest 119 3048 3058 19729833 10.1172/JCI38902 1:CAS:528:DC%2BD1MXht1GjurzJ
19. JH Lee MY Song EK Song, et al. 2009 Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway Diabetes 58 344 351 19008341 10.2337/db07-1795 1:CAS:528:DC%2BD1MXhslersLc%3D
20. DM Tartar AM VanMorlan X Wan, et al. 2010 FoxP3+RORgammat+ T helper intermediates display suppressive function against autoimmune diabetes J Immunol 184 3377 3385 20181889 10.4049/jimmunol.0903324 1:CAS:528:DC%2BC3cXjs1Wrtro%3D
21. A Chen B Gao J Zhang, et al. 2009 The HECT-type E3 ubiquitin ligase AIP2 inhibits activation-induced T cell death by catalyzing EGR2 ubiquitination Mol Cell Biol 29 5348 5356 19651900 10.1128/MCB.00407-09 1:CAS:528: DC%2BD1MXhtFOhu7bM
22. K Tanaka S Nanbara T Tanaka H Koide T Hayashi 1988 Aminotransferase activity in the liver of diabetic mice Diabetes Res Clin Pract 5 71 75 3402335 10.1016/S0168-8227(88)80081-0 1:CAS:528:DyaL1cXkslWnsLo%3D
23. SC Liang XY Tan DP Luxenberg, et al. 2006 Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides J Exp Med 203 2271 2279 16982811 10.1084/jem.20061308 1:CAS:528:DC%2BD28XhtVGls7fF (Pubitemid 44498362)
24. K Sato A Suematsu K Okamoto, et al. 2006 Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction J Exp Med 203 2673 2682 17088434 10.1084/jem.20061775 1:CAS:528:DC%2BD28Xht12htLfJ (Pubitemid 44833343)
25. T Yi Y Chen L Wang, et al. 2009 Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease Blood 114 3101 3112 19602708 10.1182/blood-2009-05-219402 1:CAS:528:DC%2BD1MXht12qur3J
26. B Bisikirska J Colgan J Luban JA Bluestone KC Herold 2005 TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs J Clin Invest 115 2904 2913 16167085 10.1172/JCI23961 1:CAS:528:DC%2BD2MXhtVygt7fN (Pubitemid 41434418)
27. I Rustenbeck A Wienbergen C Bleck A Jorns 2004 Desensitization of insulin secretion by depolarizing insulin secretagogues Diabetes 53 Suppl 3 S140 S150 15561902 10.2337/diabetes.53.suppl-3.S140 1:CAS:528:DC%2BD2cXhtVOls7rI (Pubitemid 39564536)
28. BR Marks HN Nowyhed JY Choi, et al. 2009 Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation Nat Immunol 10 1125 1132 19734905 10.1038/ni.1783 1:CAS:528:DC%2BD1MXhtV2gsbrF
29. A Reboldi C Coisne D Baumjohann, et al. 2009 C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE Nat Immunol 10 514 523 19305396 10.1038/ni.1716 1:CAS:528:DC%2BD1MXjsVGjs7Y%3D
30. RC Axtell L Steinman 2009 Gaining entry to an uninflamed brain Nat Immunol 10 453 455 19381137 10.1038/ni0509-453 1:CAS:528:DC%2BD1MXkslOgsrs%3D
31. JJ Campbell J Hedrick A Zlotnik MA Siani DA Thompson EC Butcher 1998 Chemokines and the arrest of lymphocytes rolling under flow conditions Science 279 381 384 9430588 10.1126/science.279.5349.381 1:CAS:528:DyaK1cXmtl2gtw%3D%3D (Pubitemid 28063373)
32. MC Dieu B Vanbervliet A Vicari, et al. 1998 Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites J Exp Med 188 373 386 9670049 10.1084/jem.188.2.373 1:CAS:528:DyaK1cXkvVaqtLo%3D (Pubitemid 28357765)
33. CA Power DJ Church A Meyer, et al. 1997 Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells J Exp Med 186 825 835 9294137 10.1084/jem.186.6.825 1:CAS:528: DyaK2sXmtV2itL0%3D (Pubitemid 27407344)
34. M Baba T Imai M Nishimura, et al. 1997 Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC J Biol Chem 272 14893 14898 9169459 10.1074/jbc.272.23.14893 1:CAS:528:DyaK2sXjslektr4%3D (Pubitemid 27251760)
35. K Hieshima T Imai G Opdenakker, et al. 1997 Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2 J Biol Chem 272 5846 5853 9038201 10.1074/jbc.272.9.5846 1:CAS:528: DyaK2sXhslart78%3D (Pubitemid 27102418)
36. R Hromas PW Gray D Chantry, et al. 1997 Cloning and characterization of exodus, a novel beta-chemokine Blood 89 3315 3322 9129037 1:CAS:528: DyaK2sXivVynsL8%3D (Pubitemid 27229817)
37. T Nikolic SB Geutskens N van Rooijen HA Drexhage PJ Leenen 2005 Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study Lab Invest 85 487 501 15654358 10.1038/labinvest.3700238 (Pubitemid 40523941)
38. JA Emamaullee J Davis S Merani, et al. 2009 Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice Diabetes 58 1302 1311 19289457 10.2337/db08-1113 1:CAS:528:DC%2BD1MXntFanur8%3D
39. E Nikoopour JA Schwartz K Huszarik, et al. 2010 Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes J Immunol 184 4779 4788 20363968 10.4049/jimmunol.0902822 1:CAS:528:DC%2BC3cXltVGiu7Y%3D
40. D Bending H de la Pena M Veldhoen, et al. 2009 Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice J Clin Invest 119 565 572 19188681 10.1172/JCI37865 1:CAS:528:DC%2BD1MXivF2ktL8%3D
41. N Martin-Orozco Y Chung SH Chang YH Wang C Dong 2009 Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells Eur J Immunol 39 216 224 19130584 10.1002/eji.200838475 1:CAS:528:DC%2BD1MXhs1Siurc%3D
42. AK Marwaha SQ Crome C Panagiotopoulos, et al. 2010 Cutting edge: increased IL-17-secreting T cells in children with new-onset type 1 diabetes J Immunol 185 3814 3818 20810982 10.4049/jimmunol.1001860 1:CAS:528: DC%2BC3cXhtFyisrrN
43. J Honkanen JK Nieminen R Gao, et al. 2010 IL-17 immunity in human type 1 diabetes J Immunol 185 1959 1967 20592279 10.4049/jimmunol.1000788 1:CAS:528:DC%2BC3cXptV2itr4%3D
44. KT Howitz KJ Bitterman HY Cohen, et al. 2003 Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 191 196 12939617 10.1038/nature01960 1:CAS:528:DC%2BD3sXntFCitr4%3D (Pubitemid 37150899)
45. M Pacholec JE Bleasdale B Chrunyk, et al. 2010 SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1 J Biol Chem 285 8340 8351 20061378 10.1074/jbc.M109.088682 1:CAS:528:DC%2BC3cXisl2jtr0%3D
46. B Juhasz B Varga R Gesztelyi A Kemeny-Beke J Zsuga A Tosaki 2010 Resveratrol: a multifunctional cytoprotective molecule Curr Pharm Biotechnol 11 810 818 20874691 10.2174/138920110793262079 1:CAS:528:DC%2BC3cXhsFCit7%2FF